Clinical study of non epidermoid malignancies of the paranasal sinuses


  • Y. Prabhakar Rao Department of ENT, Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
  • Punga Amreeta Kaur Department of ENT, Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India



Non epidermoid tumors, Management, Nasal endoscopy


Background: Malignancy of paranasal sinuses post challenging issues not only for surgeons but also for radiologists. Patients also try to avoid and neglect the condition. Hence clinical studies are more pertinent on this issue. Objective was to study clinical picture of non epidermoid malignancies of the paranasal sinuses.

Methods: This was a retrospective hospital based study of 30 patients with non epidermoid malignancies of the paranasal sinuses from two hospitals over a period of more than four years. Clinical characteristics were studied. CT scan, diagnostic nasal endoscopy, histopathology was done for all patients. Data was analyzed using proportions.  

Results: Majority affected were males. The male to female ratio was 2:1. Maximum cases were found in the age group of 51-60 years and all of them were males. Left side was most commonly affected. The most common presenting feature was nasal obstruction in 50% of the cases. Nasal endoscopy findings has shown that there were five cases each of pinkish red polypoid mass, pinkish grey fleshy mass, pinkish red proliferative mass, pink fleshy mass, purulent discharge and fleshy pinkish red mass. Heterogeneous soft tissue density was the most common CT scan finding. Non Hodgkins lymphoma was more common. Half of the cases were managed by maxillectomy and half of the cases were managed by radiotherapy. There was no recurrence of the tumor after 6-9 months of follow up.

Conclusions: Males are more commonly affected than females. Appropriate management of cases prevents recurrence of the tumors.


Dulgureov P, Jacobsen NS, Allal As, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma; are we making progress? Cancer. 2001;92:3012-29.

Goldenberg D, Golz A, Fradis M, Martu D, Netzer A. Jaochims HZ. Malignant tumors of the nose and paranasal sinuses; A restrospective review of 291 cases. Ear Nose Throat J. 2001;80:272-7.

Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB. Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002;24(9):821-9.

Enepekides DJ. Sinonasal undifferentiated carcinoma: an update. Curr Opin Otolaryngol Head Neck Surg. 2005;13(4):222-5.

Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA. Eastern Cooperative Oncology Group. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 2005;23(34):8646-54.

Peril F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, et al. Locally advanced paranasal sinus carcinoma: A study of 30 patients. Oncol Lett. 2017;13(3):1338–42.

Danesh-Sani SA, Sarafraz A, Chamani M, Derakhsharideh H. Paranasal sinuses malignancies: A 12-year review of clinical characteristics. Med Oral Patol Oral Cir Bucal. 2016;21(5):626-30.

Michel G, Joubert M, Delemazure AS, Espitalier F, Durand N, Malard O. Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(5):257-62.

Rhee CS, Won TB, Lee CH, Min YG, Sung MW, Kim KH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope. 2006;116(6):982-6.

Euteneuer S, Sudhoff H, Bernal-Sprekelsen M, Theegarten D, Dazert S. Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types. Laryngorhinootologie. 2004;83(1):33-9.






Original Research Articles